The Procter & Gamble Company (PRG)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 142.52 |
|---|---|
| 52-week range | 118.22 – 148.78 |
| Return, 1 month / 3 months | +11.8% / +8.7% |
| Return, 1 year / 3 years | +12.3% / +9.8% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 22.0% |
| Worst drawdown (1 year) | -13.9% |
| Average daily value traded | 0.45M EUR |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
The Procter & Gamble Company is a consumer goods company based in Cincinnati, Ohio. It makes and sells household and personal care products, including laundry detergents, diapers, shampoos, soaps, toothpastes, razors and paper goods, under brands familiar to shoppers in many countries. Its customers are everyday households, and its products reach them through retailers, wholesalers and distributors across the world. The company also supplies grooming and cleaning items for home and personal use.
The shares are listed on the Deutsche Börse Xetra in Germany under the code PRG, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
The Procter & Gamble Company (PRG) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 142.52 on 27 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 74 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.3% and over the last three months it rose 8.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.6% | ||
| From 52-week high | -4.1% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.7% | ||
| 6-month return | 13.4% | ||
| 12-month return, skipping the last month | 0.5% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.9% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.45M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.8% |
|---|---|
| 1 month | +11.8% |
| 3 months | +8.7% |
| 6 months | +13.4% |
| 1 year | +12.3% |
| 3 years | +9.8% |
| 5 years | +30.5% |
Signals
| 50-day / 200-day average | 130.58 / 127.72 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.47 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Jul 2026 | USD 0.9682 |
| 24 Apr 2026 | USD 0.9682 |
| 23 Jan 2026 | USD 0.9400 |
| 24 Oct 2025 | USD 0.9400 |
| 18 Jul 2025 | USD 0.9400 |
| 22 Apr 2025 | USD 0.9400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.